Arkolith/Insider Trading/FATE/Form 4

Valamehr Bahram

Chief R&D OfficerFATE THERAPEUTICS INC (FATE) · full profile →Form 4 · filed Jan 10, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$49K
Net Open-Market Flow
-$49K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2024Sell(S)11K$4.38$49K158K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-003650) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML